Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Commun Biol ; 7(1): 811, 2024 Jul 04.
Artigo em Inglês | MEDLINE | ID: mdl-38965360

RESUMO

Experimental autoimmune encephalomyelitis (EAE) is a demyelinating disease affecting the central nervous system (CNS) in animals that parallels several clinical and molecular traits of multiple sclerosis in humans. Herpes simplex virus type 1 (HSV-1) infection mainly causes cold sores and eye diseases, yet eventually, it can also reach the CNS, leading to acute encephalitis. Notably, a significant proportion of healthy individuals are likely to have asymptomatic HSV-1 brain infection with chronic brain inflammation due to persistent latent infection in neurons. Because cellular senescence is suggested as a potential factor contributing to the development of various neurodegenerative disorders, including multiple sclerosis, and viral infections may induce a premature senescence state in the CNS, potentially increasing susceptibility to such disorders, here we examine the presence of senescence-related markers in the brains and spinal cords of mice with asymptomatic HSV-1 brain infection, EAE, and both conditions. Across all scenarios, we find a significant increases of senescence biomarkers in the CNS with some differences depending on the analyzed group. Notably, some senescence biomarkers are exclusively observed in mice with the combined conditions. These results indicate that asymptomatic HSV-1 brain infection and EAE associate with a significant expression of senescence biomarkers in the CNS.


Assuntos
Encéfalo , Senescência Celular , Herpes Simples , Herpesvirus Humano 1 , Esclerose Múltipla , Animais , Camundongos , Encéfalo/virologia , Encéfalo/patologia , Encéfalo/metabolismo , Esclerose Múltipla/virologia , Esclerose Múltipla/patologia , Esclerose Múltipla/metabolismo , Herpesvirus Humano 1/fisiologia , Herpesvirus Humano 1/patogenicidade , Herpes Simples/virologia , Herpes Simples/patologia , Feminino , Camundongos Endogâmicos C57BL , Encefalomielite Autoimune Experimental/virologia , Encefalomielite Autoimune Experimental/patologia , Encefalomielite Autoimune Experimental/metabolismo , Fenótipo , Sistema Nervoso Central/virologia , Sistema Nervoso Central/metabolismo , Sistema Nervoso Central/patologia , Medula Espinal/virologia , Medula Espinal/metabolismo , Medula Espinal/patologia , Biomarcadores/metabolismo , Encefalite por Herpes Simples/virologia , Encefalite por Herpes Simples/patologia , Encefalite por Herpes Simples/metabolismo
2.
Brain Behav Immun ; 89: 480-490, 2020 10.
Artigo em Inglês | MEDLINE | ID: mdl-32717399

RESUMO

The incidence of infectious diseases affecting the central nervous system (CNS) has been increasing over the last several years. Among the reasons for the expansion of these diseases and the appearance of new neuropathogens are globalization, global warming, and the increased proximity between humans and wild animals due to human activities such as deforestation. Neurotropism affecting normal brain function is shared by organisms such as viruses, bacteria, fungi, and parasites. Neuroinfections caused by these agents activate immune responses, inducing neuroinflammation, excitotoxicity, and neurodegeneration. Purinergic signaling is an evolutionarily conserved signaling pathway associated with these neuropathologies. During neuroinfections, host cells release ATP as an extracellular danger signal with pro-inflammatory activities. ATP is metabolized to its derivatives by ectonucleotidases such as CD39 and CD73; ATP and its metabolites modulate neuronal and immune mechanisms through P1 and P2 purinergic receptors that are involved in pathophysiological mechanisms of neuroinfections. In this review we discuss the beneficial or deleterious effects of various components of the purinergic signaling pathway in infectious diseases that affect the CNS, including human immunodeficiency virus (HIV-1) infection, herpes simplex virus type 1 (HSV-1) infection, bacterial meningitis, sepsis, cryptococcosis, toxoplasmosis, and malaria. We also provide a description of this signaling pathway in emerging viral infections with neurological implications such as Zika and SARS-CoV-2.


Assuntos
Infecções do Sistema Nervoso Central/metabolismo , Receptores Purinérgicos P1/metabolismo , Receptores Purinérgicos P2X/metabolismo , Receptores Purinérgicos P2Y/metabolismo , Complexo AIDS Demência/metabolismo , Betacoronavirus , COVID-19 , Infecções por Coronavirus/metabolismo , Encefalite por Herpes Simples/metabolismo , Humanos , Malária/metabolismo , Meningites Bacterianas/metabolismo , Meningite Criptocócica/metabolismo , Pandemias , Pneumonia Viral/metabolismo , SARS-CoV-2 , Sepse/metabolismo , Transdução de Sinais , Toxoplasmose Cerebral/metabolismo , Infecção por Zika virus/metabolismo
3.
J Neuroimmunol ; 224(1-2): 62-5, 2010 Jul 27.
Artigo em Inglês | MEDLINE | ID: mdl-20605228

RESUMO

The interaction between a microorganism and a potential host may modify each other in multiple ways. Because of their central role in controlling leukocyte trafficking and activation, chemokines may be essential in defining these interactions. Here, we describe potential uses of intravital microscopy to define the role of chemokines and their receptors in the context of HSV-1 infection and EAE. We show that CCL5 plays a major role in driving neuropathology by mediating leukocyte adhesion and consequent migration in HSV-1 encephalitis. In contrast, CCR5 is important to attract cell types that modulate negatively CNS damage at the cost of allowing greater viral replication in the brain. Finally, intravital microscopy studies were crucial to determine that induction of leukocyte adhesion and subsequent emigration into the CNS is a major mechanism of action of CCL2 in EAE.


Assuntos
Doenças do Sistema Nervoso Central/imunologia , Doenças do Sistema Nervoso Central/metabolismo , Quimiocinas/fisiologia , Encefalite por Herpes Simples/imunologia , Encefalomielite Autoimune Experimental/imunologia , Mediadores da Inflamação/fisiologia , Microscopia de Fluorescência/métodos , Animais , Doenças do Sistema Nervoso Central/patologia , Quimiocinas/análise , Encefalite por Herpes Simples/metabolismo , Encefalite por Herpes Simples/patologia , Encefalomielite Autoimune Experimental/metabolismo , Encefalomielite Autoimune Experimental/patologia , Humanos , Mediadores da Inflamação/análise
4.
Neurosci Lett ; 479(1): 58-62, 2010 Jul 19.
Artigo em Inglês | MEDLINE | ID: mdl-20478363

RESUMO

Herpes simplex virus-1 (HSV-1) is a pathogen for humans that may cause severe encephalitis. Tumor necrosis factor alpha (TNF-alpha) plays a role in several viral diseases of the central nervous system (CNS). The classic proinflammatory activities of TNF-alpha are mediated mainly through activation of the receptor 1 for TNF-alpha (TNFR1). However, when HSV-1 is inoculated in the periphery, TNF-alpha seems to protect C57Bl/6 mice against encephalitis by a mechanism independent of TNFR1. This study aims to investigate the role of TNFR1 in HSV-1 encephalitis induced by the inoculation of the virus into the brain. Wild-type C57BL/6 (WT) and TNFR1(-/-) were inoculated with 10(2) plaque-forming units of HSV-1 by the intracranial route. Infection with HSV-1 was lethal in TNFR1(-/-) mice in early times after infection. TNFR1(-/-) mice had reduced expression of the chemokines CCL3 and CCL5, and decreased leukocyte adhesion in the brain vasculature compared to WT mice 4 days post-infection (dpi). At this time point TNFR1(-/-) infected mice also had higher HSV-1 viral replication and more injuries in the brain, especially in the hippocampus. In conclusion, TNFR1 seems to play a relevant role in the control of viral replication in the CNS when HSV-1 is inoculated by intracranial route.


Assuntos
Encefalite por Herpes Simples/metabolismo , Herpesvirus Humano 1 , Receptores Tipo I de Fatores de Necrose Tumoral/metabolismo , Animais , Encéfalo/irrigação sanguínea , Encéfalo/metabolismo , Encéfalo/patologia , Quimiocina CCL3/metabolismo , Quimiocina CCL5/metabolismo , Encefalite por Herpes Simples/imunologia , Encefalite por Herpes Simples/patologia , Endotélio Vascular/metabolismo , Endotélio Vascular/patologia , Leucócitos/metabolismo , Leucócitos/patologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Receptores Tipo I de Fatores de Necrose Tumoral/genética , Índice de Gravidade de Doença , Análise de Sobrevida
5.
Neurosci Lett ; 445(1): 18-22, 2008 Nov 07.
Artigo em Inglês | MEDLINE | ID: mdl-18782601

RESUMO

Herpes simplex virus type 1 (HSV-1) is a human pathogen that may cause severe encephalitis. The development of experimental models of HSV-1 encephalitis is relevant for the comprehension of the immune mechanisms involved in this infection. C57BL/6 mice were inoculated intracranially with 10(4) PFU of neurotropic HSV-1. All animals developed signs of encephalitis and died until day 6 post-infection (pi). Using intravital microscopy, we demonstrated increased leukocyte rolling and adhesion in the brain microvasculature of infected mice at days 1, 3 and 5 pi. The infection was followed by a significant increase in chemokine levels, including CCL2, CCL3, CCL5, CXCL1 and CXCL9. TNF-alpha also showed a significant increase at day 3 pi. Histological analyses demonstrated diffuse meningoencephalitis characterized mainly by mononuclear cell infiltrates. The present model of HSV-1 encephalitis exhibits high mortality in the very first days of infection. Accordingly, there were increased rolling and adhesion of leukocytes along the brain endothelium wall and a high expression of chemokines in the central nervous system. These results corroborate the role of chemokines in leukocyte recruitment following HSV-1 infection in the central nervous system.


Assuntos
Sistema Nervoso Central/patologia , Quimiocinas/metabolismo , Encefalite por Herpes Simples/patologia , Herpesvirus Humano 1 , Leucócitos/fisiologia , Regulação para Cima/fisiologia , Animais , Movimento Celular/fisiologia , Quimiocinas/genética , Modelos Animais de Doenças , Encefalite por Herpes Simples/metabolismo , Endotélio/patologia , Contagem de Leucócitos , Leucócitos/imunologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Fatores de Tempo
6.
J Alzheimers Dis ; 14(3): 259-69, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18599953

RESUMO

Herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) belong to the family Herpesviridae, the subfamily Alphaherpesvirinae, and the genus Simplexvirus. They are ubiquitous, neurotropic, and the most common pathogenic cause of sporadic acute encephalitis in humans. Herpes simplex encephalitis (HSE) is associated with a high mortality rate and significant neurological, neuropsychological, and neurobehavioral sequelae, which afflict patients for life. HSV-1 has been suggested as an environmental risk factor for Alzheimer's disease. However, the mechanisms involved in HSV-1 infection that may trigger the neurodegenerative process are still unknown. In general, HSV-1 induced cytoskeletal alterations reported to date involve the overall disruption of one or more elements of the cytoskeleton in cell lines. Axonal injury has recently attracted attention as a key predictor for the outcome of a number of brain disorders. Here we show that infection of mice neuronal cultures with HSV-1 result in marked neurite damage and neuronal death. Furthermore, in this in vitro model of infection, neurons manifested considerable alterations in microtubule dynamics and tau hyperphosphorylation. These results suggest a possible link between HSV-1 infection and neuronal cytoskeletal disruption.


Assuntos
Citoesqueleto/patologia , Encefalite por Herpes Simples/complicações , Herpesvirus Humano 1/isolamento & purificação , Degeneração Neural/patologia , Degeneração Neural/virologia , Western Blotting , Células Cultivadas , Citoesqueleto/metabolismo , Encefalite por Herpes Simples/metabolismo , Imunofluorescência , Humanos , Hibridização in Situ Fluorescente , Degeneração Neural/metabolismo , Neuritos/patologia , Fosforilação , Tubulina (Proteína)/metabolismo , Proteínas tau/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA